Ronald L. Wilder - Concepedia

Author

Ronald L. Wilder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Also Known As

Pope, Richard, R L Wilder, RONALD L. WILDER, Ronald L Wilder, Ronald L. Wilder

132

Publications

32.5K

Citations

H-Index

119

Concepts

All Affiliations

National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health University of Utah National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Dental and Craniofacial Research

About

Ronald L. Wilder is an author at National Institute of Arthritis and Musculoskeletal and Skin Diseases specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	5.4K
2	Allergy	4	4	480
3	Health Sciences	2	2	24
4	Natural Sciences	2	2	30
5	Public Health	2	2	130

Ronald L. Wilder

Publications

28.6K

Citations

H-Index

Page 1

	Year	Citations
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Frank C. Arnett, Steven M. Edworthy, D. Blöch, Arthritis & Rheumatism	1988	19.8K
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Hajime Sano, Yutaka Kawahito, Ronald L. Wilder, PubMed InflammationTumor BiologyAnti-inflammatoryOncologyCox-2 Polypeptides	1995	1.1K
Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis Pazit Ben-Av, Leslie J. Crofford, Ronald L. Wilder, FEBS Letters	1995	568
Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia Leslie J. Crofford, Stanley R. Pillemer, Konstantine T. Kalogeras, Arthritis & Rheumatism	1994	511
Autocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in Vivo Katia Karalis, Hajime Sano, Jeffrey M. Redwine, Science Chronic Inflammatory DiseasesImmunologyGlucocorticoidImmune SystemInflammation	1991	485
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial Nicole Sherry, William Hagopian, Johnny Ludvigsson, The Lancet Type 1Disease ManagementDiabetes ManagementHealth PolicyDiabetes	2011	484
Histamine Potently Suppresses Human IL-12 and Stimulates IL-10 Production via H2 Receptors Ilia J. Elenkov, Elizabeth Webster, Dimitris A. Papanicolaou, The Journal of Immunology	1998	371
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset Raphaela Goldbach‐Mansky, Jennifer Lee, Angela McCoy, Arthritis Research & Therapy ImmunologyRecent OnsetStatement Of FindingsPsoriatic ArthritisAxial Spondyloarthritis	2000	355
IL-12, TNF-α, and Hormonal Changes during Late Pregnancy and Early Postpartum: Implications for Autoimmune Disease Activity during These Times Ilia J. Elenkov, Ronald L. Wilder, Vladimir K. Bakalov, The Journal of Clinical Endocrinology & Metabolism	2001	271
Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes Amrey A. Link, Tomoshige Kino, James A. Worth, The Journal of Immunology Human Il-12ImmunologyImmune RegulationImmunologic MechanismCellular Pharmacology	2000	243

Page 1